Illuminating research one patient at a time.

Home
About
For Providers
Sites
Trials
Contact
Careers
- Internship Opportunities

Our Patients Come First.

We value our patients for who they are. Contact us today so we can work on getting the care you need.

The IRAKLIA study (Sanofi)

A randomized, Phase 3, open-label study evaluating subcutaneous versus intravenous administration of isatuximab in combination with pomalidomide and dexamethasone in adult patients with relapsed and/or refractory multiple myeloma.

Learn more about the study

If you are interested in learning more about the IRAKLIA study, please fill out the form below to see if you may be eligible. By filling out the questionnaire, you are under no obligation to participate in the study. All information provided will be kept confidential.

Learn More

Please assure provided phone number is accessible directly by the affected individual as our medical staff will reach out for additional health details.

A member of the study team should be in contact with you within 24hrs.

* Indicates required field

Name *

First

Last

Email *

Phone Number *

Do you have Multiple Myeloma and did you receive at least one prior line of anti-myeloma therapy? *

Yes No

Are you at least 18 years of age? *

Yes No

Do you have any significant cardiac dysfunction? *

Yes No

If you are a woman of childbearing age or male participant with women of childbearing age, would you agree to use a high effective method of birth control throughout the study? *

Yes No

Are you a patient of Genesis Medical Group? *

Yes No

If no, would you be willing to send medical records and establish care with Genesis Medical Group? *

Yes No Not sure

Do you own a smartphone or computer with access to the internet? *

Yes No

Participation in the study can last approx. 30 months, does this length of time seem like it would be an issue? *

Yes No

Please list any other known health diagnosis: *

Do you consent to allow us to contact you regarding future studies that we open that may treat your myeloma? *

Yes, please add me to your list of future candidates No, please do not contact me for future studies

Submit

Support

Services

Principal Investigator Development (Fast Track)
Clinical Trial Population Analysis and Matching
Clinical Trial Management Services
Site Development and Establishment
Clinical Trial Software (empowered by AI)

Connect

[email protected]